Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Tatsunori Miyaoka"'
Autor:
Kotaro Sakamoto, Seigo Iwata, Zihao Jin, Lu Chen, Tatsunori Miyaoka, Mei Yamada, Kaiga Katahira, Rei Yokoyama, Ami Ono, Satoshi Asano, Kotaro Tanimoto, Rika Ishimura, Shinsaku Nakagawa, Takatsugu Hirokawa, Yukio Ago, Eijiro Miyako
Publikováno v:
JACS Au, Vol 4, Iss 8, Pp 2811-2817 (2024)
Externí odkaz:
https://doaj.org/article/aa113cdf44a34434ada51d6d3b16c4ca
Autor:
Kotaro Sakamoto, Lu Chen, Tatsunori Miyaoka, Mei Yamada, Teruaki Masutani, Kenji Ishimoto, Nobumasa Hino, Shinsaku Nakagawa, Satoshi Asano, Yukio Ago
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Worldwide, more than 20 million people suffer from schizophrenia, but effective and definitive new therapeutic drugs/treatments have not been established. Vasoactive intestinal peptide receptor 2 (VIPR2) might be an attractive drug target for the tre
Externí odkaz:
https://doaj.org/article/a48f0731bf1640b887ab23400b1a5cfb
Autor:
Shuto Takeuchi, Takuya Kawanai, Ryosuke Yamauchi, Lu Chen, Tatsunori Miyaoka, Mei Yamada, Satoshi Asano, Atsuko Hayata-Takano, Takanobu Nakazawa, Koji Yano, Naotaka Horiguchi, Shinsaku Nakagawa, Kazuhiro Takuma, James A. Waschek, Hitoshi Hashimoto, Yukio Ago
Publikováno v:
Frontiers in Neuroscience, Vol 14 (2020)
Clinical studies have shown that microduplications at 7q36.3, containing VIPR2, confer significant risk for schizophrenia and autism spectrum disorder (ASD). VIPR2 gene encodes the VPAC2 receptor for vasoactive intestinal peptide (VIP) and pituitary
Externí odkaz:
https://doaj.org/article/5aacf9b8b65c485995cafa3a29a95fc0